Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its ...

Heartflow on Wednesday said it now plans to sell nearly 16.7 million shares at between $17 and $18 apiece in the IPO, compared with prior plans to offer 12.5 million shares at between $15 and $17 each ...

Medical technology company Heartflow said on Wednesday it was aiming to raise as much as $300 million in its upsized initial public offering in the United States.

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

This briefing covers Heartflow's upcoming IPO aiming for a $1.32 billion valuation, research linking artificial sweeteners to ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

Toledo's profit forecast boost, Heartflow's IPO plans, research linking artificial sweeteners to less effective cancer ...